CYTH: Cyclo Therapeutics, Inc. Stock

by  •  • Comments Off on CYTH: Cyclo Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 20.06
Enterprise Value ($M) 31.31
Book Value ($M) -13.47
Book Value / Share -0.47
Price / Book -1.49
NCAV ($M) -15.47
NCAV / Share -0.54
Price / NCAV -1.30

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -4.43
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.16
Current Ratio 0.17

Balance Sheet (mrq) ($M)
Current Assets 3.26
Assets 5.25
Liabilities 18.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 45.79
2023-10-24 13D/A Rafael Holdings, Inc. 49.00 5.13

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: March 31, 2024 ☐Transition Report Pursuant to
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark one)
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark one)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-25 21,251 43,419 48.94
2024-11-22 311 17,316 1.80
2024-11-21 4,712 10,794 43.65
2024-11-20 283 6,247 4.53

(click for more detail)

Similar Companies
CYCC – Cyclacel Pharmaceuticals, Inc. CYCN – Cyclerion Therapeutics, Inc.
CYRX – Cryoport, Inc. DARE – Daré Bioscience, Inc.
DERM – Journey Medical Corporation


Financial data and stock pages provided by
Fintel.io